EMA Proposes Extending Remote QP Batch Certification Post-Pandemic
Executive Summary
Stakeholders given one month to weigh in on proposal to allow relaxations introduced in response to COVID-19-related travel restrictions to continue on a routine basis.
You may also be interested in...
EFPIA Supports Uniform Approach By EU Member States On Remote Batch Certification
The European federation of research-based drug companies has made suggestions to ensure the consistent adoption of an EU proposal that seeks to continue the flexibilities that were introduced in response to COVID-19-related travel restrictions.
EU Allows Pharma To Temporarily Prioritize Reporting For COVID-19 Adverse Events
Drug companies unable to continue with standard reporting of suspected adverse reactions to the EU pharmacovigilance database can temporarily prioritize their reporting activities to focus on COVID-19 related safety events.
As Annex 16 Revision Proceeds, QPs Urged to Focus on Quality Systems in Certifying Batches
Qualified persons should respond to the complexities of globalization by leveraging quality systems rather than confirming every detail, Pfizer official says. Proposed revision to Annex 16 of EU GMPs defines numerous tasks QPs can delegate.